SRP6167
HGH human
recombinant, expressed in HEK 293 cells, ≥95% (SDS-PAGE)
Manufacturer: Sigma Aldrich
Synonym(S): GHN, Growth hormone 1 (GH1), Human growth hormone, Pituitary growth hormone, Somatotropin
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 10 μG | SRP6167-10-μG | In Stock | ₹ 36,989.03 |
SRP6167 - 10 μG
In Stock
Quantity
1
Base Price: ₹ 36,989.03
GST (18%): ₹ 6,658.025
Total Price: ₹ 43,647.055
biological source
human
recombinant
expressed in HEK 293 cells
Assay
≥95% (SDS-PAGE)
form
lyophilized
potency
0.4-2 ng/mL
mol wt
22 kDa (monomer, non-glycosylated)
packaging
pkg of 10 μg
technique(s)
cell culture | mammalian: suitable
impurities
<1.0 EU/μg
NCBI accession no.
P01241
Related Products
Description
- General description: HGH is a member of the somatotropin/prolactin family of hormones which play an important role in growth control. HGH can promote bone and cartilage growth as well as increase protein synthesis through liver somatomedin and tissue polypeptide growth factor, correct the post-traumatic state of negative nitrogen and hypoproteinemia induced by severe infection and cirrhosis; stimulate immunoglobulin synthesis, stimulate the proliferation of lymphoid tissue, macrophages and lymphocyte, and accelerate wound healing; promote myocardial protein synthesis, increase myocardial contractility and reduce myocardial oxygen consumption; regulating fat metabolism, reducing serum cholesterol, low - density lipoprotein level.
- Physical form: Lyophilized from a TBS solution.
- Preparation Note: Centrifuge the vial prior to opening.
- Reconstitution: Reconstitute in sterile PBS containing 0.1% endotoxin-free recombinant human serum albumin.
SAFETY INFORMATION
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
biological source: human
recombinant: expressed in HEK 293 cells
Assay: ≥95% (SDS-PAGE)
form: lyophilized
potency: 0.4-2 ng/mL
mol wt: 22 kDa (monomer, non-glycosylated)
packaging: pkg of 10 μg
technique(s): cell culture | mammalian: suitable
impurities: <1.0 EU/μg
NCBI accession no.: P01241
biological source:
human
recombinant:
expressed in HEK 293 cells
Assay:
≥95% (SDS-PAGE)
form:
lyophilized
potency:
0.4-2 ng/mL
mol wt:
22 kDa (monomer, non-glycosylated)
packaging:
pkg of 10 μg
technique(s):
cell culture | mammalian: suitable
impurities:
<1.0 EU/μg
NCBI accession no.:
P01241
biological source: human
recombinant: expressed in HEK 293 cells
Assay: ≥97% (SDS-PAGE)
form: lyophilized powder
potency: 0.15-0.7 μg/mL
mol wt: calculated mol wt 15 kDaobserved mol wt 18-23 kDa (DTT-reduced. Protein migrates due to glycosylation. Thr 103 is the predicted N-terminus .)
packaging: pkg of 10 μg
technique(s): __
impurities: <1 EU/μg endotoxin (LAL test)
NCBI accession no.: __
biological source:
human
recombinant:
expressed in HEK 293 cells
Assay:
≥97% (SDS-PAGE)
form:
lyophilized powder
potency:
0.15-0.7 μg/mL
mol wt:
calculated mol wt 15 kDaobserved mol wt 18-23 kDa (DTT-reduced. Protein migrates due to glycosylation. Thr 103 is the predicted N-terminus .)
packaging:
pkg of 10 μg
technique(s):
__
impurities:
<1 EU/μg endotoxin (LAL test)
NCBI accession no.:
__
biological source: human
recombinant: expressed in HEK 293 cells
Assay: ≥92% (SDS-PAGE)
form: lyophilized powder
potency: __
mol wt: calculated mol wt 25.4 kDaobserved mol wt 28-33 kDa (DTT-reduced. Protein migrates due to glycosylation. Glu 19 is the predicted N-terminus.)
packaging: pkg of 10 μg
technique(s): __
impurities: <1 EU/μg endotoxin (LAL test)
NCBI accession no.: __
biological source:
human
recombinant:
expressed in HEK 293 cells
Assay:
≥92% (SDS-PAGE)
form:
lyophilized powder
potency:
__
mol wt:
calculated mol wt 25.4 kDaobserved mol wt 28-33 kDa (DTT-reduced. Protein migrates due to glycosylation. Glu 19 is the predicted N-terminus.)
packaging:
pkg of 10 μg
technique(s):
__
impurities:
<1 EU/μg endotoxin (LAL test)
NCBI accession no.:
__
biological source: human
recombinant: expressed in HEK 293 cells
Assay: ≥95% (SDS-PAGE)
form: lyophilized powder
potency: __
mol wt: calculated mol wt 20.2 kDaobserved mol wt 28-33 kDa (DTT-reduced. Protein migrates due to glycosylation. Arg 29 is the predicted N-terminus.)
packaging: pkg of 10 μg
technique(s): __
impurities: <1 EU/μg endotoxin (LAL test)
NCBI accession no.: __
biological source:
human
recombinant:
expressed in HEK 293 cells
Assay:
≥95% (SDS-PAGE)
form:
lyophilized powder
potency:
__
mol wt:
calculated mol wt 20.2 kDaobserved mol wt 28-33 kDa (DTT-reduced. Protein migrates due to glycosylation. Arg 29 is the predicted N-terminus.)
packaging:
pkg of 10 μg
technique(s):
__
impurities:
<1 EU/μg endotoxin (LAL test)
NCBI accession no.:
__